The impact of import on the competitive situation on the market for medicinal products in Poland in the years 2010-2018
The association of Polish parallel importers SIRPL analysed the direct and indirect savings coming from parallel imports in the country in a report that was audited by Deloitte. Savings amounted to more than €720 million between 2010 and 2018. Just in 2018, savings added up to €124 million. The report presents the distribution of the savings between patients and the National Health Fund for reimbursed medicines as well.